Start-Up Previews, September 2015
This Month's Profile Group, Parkinson’s Disease: Start-Ups Seek Breakthroughs And Money, features profiles of MentiNova, Parkure and Prexton Therapeutics. Plus these Start-Ups Across Health Care: Apifix, Monopar Therapeutics, MitoGenetics, Preora Diagnostics, and Viking Therapeutics.
You may also be interested in...
ApiFix Ltd. says its minimally invasive, fusionless technique for treating adolescent idiopathic scoliosis effectively remedies three hotly contested areas in spine: motion preservation, minimally invasive techniques and deformity correction. The device consists of an implantable ratcheting rod that only increases in length over a short segment of the spine, at the apex of the scoliotic curve, compared to a long segment) required for fusion surgery, and it requires only two pedicle screws to anchor the rod.
Just as the PAP smear has drastically reduced the incidence and number of deaths from cervical cancer over the decades, Preora Diagnostics Inc. expects its low-cost test to be an effective prescreening tool for lung cancer, in the convenience of a primary-care setting. The start-up believes its test will be able to identify asymptomatic stage 1 and stage 2 cancers.
In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)